whereas the introduction of phenylalanine , alanine , or ornithine residues in position 31 led to compounds that still displayed peripheral agonist properties , the presence of a negative charge in the side chain of the amino acid in position 31 prevented the binding of the peptide to both pancreatic and brain binding sites .
C0001898
alanine
C0002520
amino acid